Salts and Derivatives of Active Pharmaceutical Ingredients (API)
The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances.
At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.
Products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"
Sort by
Dimethyl Phthalate
CAS:Formula:C10H10O4Color and Shape:White To Off-White SolidMolecular weight:194.19Chloromethyl Polystyrene Resin cross-linked with 2% DVB (200-400mesh) (2.0-2.7mmol/g)
CAS:Color and Shape:White to Light yellow powder to crystalLosartan Related Compound B (2-Butyl-4-chloro-(1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methyl acetate)
CAS:Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormula:C24H25ClN6O2Color and Shape:PowderMolecular weight:464.172752-[(4-Chloro-2-nitrophenyl)amino]benzoic Acid
CAS:Controlled ProductApplications 2-[(4-Chloro-2-nitrophenyl)amino]benzoic Acid is an diazepinomicin derivative with potential antcancer activity. 2-[(4-Chloro-2-nitrophenyl)amino]benzoic Acid is also an impurity in the synthesis of Clozepine (C587500), an antipsychotic. References Yu, Y.G., et al.: Lett. Drug. Design. Discov., 10, 369 (3013);Formula:C13H9ClN2O4Color and Shape:NeatMolecular weight:292.67Argatroban-d3 (Mixture Of Diastereomers)
CAS:Formula:C23H33N6O5SD3Color and Shape:White To Off-White SolidMolecular weight:511.66((R)-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)((S)-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methanone
CAS:Controlled ProductImpurity Solifenacin EP Impurity D Applications ((R)-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)((S)-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl)methanone is a possible impurity of solifenacin (S676700) which is a muscarinic M3 receptor antagoinst. Solifenacin is used in treatment of urinary incontinence. References Ikeda K., et al.: Arch. Pharmacol., 366, 97, (2002); Chapple, C.R., et al.: Br. J. Urol., 93, 303 (2004); Ohtake, A., et al.: Eur. J. Pharmacol., 492, 243 (2004); Brunton, S., et al.: Curr. Med. Res. Opin., 21, 71 (2005); Habb, F., et al.: Eur. Urol. 47, 376 (2005); Payne, C.K., et al.: Drugs, 66, 175 (2006)Formula:C31H28N2OColor and Shape:NeatMolecular weight:444.57
![2-[(4-Chloro-2-nitrophenyl)amino]benzoic Acid](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FTR%2Fthumb-webp%2FC373950.webp&w=3840&q=75)
